← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 24, 2022Last known activity
Sep 16, 2024
Timeline
Drugs by trial phase (2 distinct, 3 trials)
Recent trials (5)
- NCT06630169OfficialPhase 2Sep 16, 2024
- NCT06630169Lead sponsorPhase 2Sep 16, 2024
- NCT06041256Lead sponsorPhase 1/Phase 2Oct 18, 2023
- NCT06041256Study directorPhase 1/Phase 2Oct 18, 2023
- NCT05309135Lead sponsorPhase 1Mar 24, 2022
Details
- Founded
- Seattle, WA, US
- Last known activity
- Sep 16, 2024